Company Number: 14469628

Analysis Date: 2025-07-20 13:12 UTC

Financial Health Assessment for EMAGLAM LTD

---

1. Financial Health Score: D

Explanation:
EMAGLAM LTD demonstrates very weak financial health. The company shows minimal net current assets and negligible net assets, indicating a fragile liquidity position and limited financial cushion to absorb shocks. While it is not insolvent, the "symptoms" of tight working capital and low equity suggest vulnerability to operational or market fluctuations. Given its very recent incorporation and small scale, the company is in the early stages of financial development but currently exhibits signs of distress typical of a "financial patient" with mild but concerning symptoms.

---

2. Key Vital Signs

Metric	Latest Year (2024)	Interpretation
Current Assets	£3,453	Very low level of liquid and short-term assets; limited buffer.
Cash	£3,390	Almost all current assets held in cash, which is positive for liquidity.
Debtors	£63	Very low trade receivables, suggests minimal sales or slow invoicing.
Current Liabilities	£3,434	Almost equal to current assets; risk of cash flow strain.
Net Current Assets	£19	Marginal positive working capital; "just breathing" financially.
Net Assets	£19	Extremely low equity base; thin capitalisation.
Shareholders’ Funds	£18	Reflects almost no retained earnings or capital reserves.
Average Employees	4	Small workforce, consistent with micro/small company size.
Turnover	Not disclosed	Lack of turnover data limits assessment of operational performance.

Interpretation:

• The company’s liquidity is precarious: current assets barely cover current liabilities, akin to a patient with borderline vital signs.
• Cash dominance in current assets is a positive sign — cash is the "oxygen" keeping the business alive.
• Extremely low net assets and shareholders’ funds indicate a fragile financial "immune system" with little capacity to withstand shocks.
• Minimal debtors could be either a symptom of low sales or efficient cash collection.
• The company shows no signs of insolvency but is financially "underweight" and vulnerable.

---

3. Diagnosis

EMAGLAM LTD is a very young private limited company, incorporated in late 2022, operating in a niche sector classified as "Activities of other membership organizations not elsewhere classified." Its financial statements reveal a company with very limited scale and financial resources.

The balance sheet is dominated by cash, with minimal receivables and current liabilities nearly equal to current assets. This indicates the company is maintaining liquidity but has very little buffer. The negligible net assets and shareholders’ funds imply that the company has not yet accumulated significant retained earnings or capital, which is typical for a start-up but also a risk if losses occur.

The small size and limited financial data (no turnover disclosed) mean the company may be in its initial growth phase or operating with very restricted business. The "symptoms" suggest cautious management but also signal the need for growth or capital injection to strengthen financial health.

---

4. Recommendations

• Improve Revenue Visibility: Begin tracking and clearly reporting turnover to better diagnose operational performance and growth trends. This will provide insight into whether low debtors reflect low sales or efficient collections.

• Build Working Capital: Although cash is currently adequate, the company should aim to grow its net current assets to build a stronger liquidity buffer. This can be achieved by improving cash generation from operations or securing short-term funding lines.

• Strengthen Equity Base: Consider capital injections or retained earnings accumulation to increase shareholders' funds, improving the company's financial resilience.

• Monitor Cash Flow Closely: Given the tight margin between current assets and liabilities, regular cash flow forecasting is critical to avoid liquidity crises.

• Cost Management: Maintain tight control on operating expenses and wages (noted as a significant part of liabilities) to prevent cash drain.

• Strategic Growth: Explore avenues to increase sales and diversify income streams while controlling costs to transition from fragile financial health to a more robust position.

• Compliance and Reporting: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

---